Clinical chemistry substrate IVDs

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
01-11-2019

から入手可能:

Emergo Asia Pacific Pty Ltd T/a Emergo Australia

クラス:

Class 2

製:

Associates Of Cape Cod Inc 124 Bernard E Saint Jean Drive, East Falmouth, Massachusetts United States Of America

治療領域:

CT833 - Clinical chemistry substrate IVDs

適応症:

The Fungitell assay is a protease zymogen-based colorimetric assay for the qualitative detection of (1-3)-beta-D-glucan in the serum of patients with symptoms of, or medical conditions predisposing the patient to, invasive fungal infection. The serum concentration of (1-3)-beta-D-glucan, a major cell-wall component of various medically important fungi, can be used as an aid in the diagnosis of deep-seated mycoses and fungemias. A positive result does not indicate which genus of fungi may be causing infection.

認証ステータス:

A

承認日:

2019-09-04

この製品に関連するアラートを検索

ドキュメントの履歴を表示する